Abstract:Background: Developmental dysplasia of the hip (DDH) is a highly prevalent hip disease among children. However, its pathogenesis remains unclear. MicroRNAs (miRNA) are important regulators of cartilage development. In a previous study, high-throughput miRNA sequencing of tissue samples from an animal model of DDH showed a low level of miR-1-3p in the cartilage of the acetabular roof (ARC), but its role in DDH pathogenesis was not addressed. Therefore, our aim here was to investigate the effects of miR-1-3p in the ARC. Methods: The diagnosis of acetabular dysplasia was confirmed with X-ray examination, while imaging and HE staining were conducted to further evaluate the ARC thickness in each animal model. FISH was employed to verify miR-1-3p expression in the ARC and chondrocytes. The miR-1-3p target genes were predicted by a bioinformatics database. A dual-luciferase reporter assay was used to confirm the targeting relationship between miR-1-3p and SOX9. The gene expression of miR-1-3p, SOX9, RUNX2 and collagen type X was evaluated by qPCR analysis. The protein expression of SOX9, RUNX2 and collagen type X was detected by western blot analysis. The levels of SOX9, RUNX2, and collagen type X in the ARC were further assessed via immunohistochemistry analysis. Finally, Alizarin Red S staining was used to observe the mineralized nodules produced by the chondrocytes. Results: We observed low expression of miR-1-3p in the ARC of animals with DDH. SOX9 is a miR-1-3p target gene. Using miR-1-3p silencing technology in vitro, we demonstrated significantly reduced chondrocyte-generated mineralized nodules compared to those of the control. We also confirmed that with miR-1-3p silencing, SOX9 expression was upregulated, whereas the expression of genes associated with endochondral osteogenesis such as RUNX2 and collagen type X was downregulated. To confirm the involvement of miR-1-3p silencing in abnormal ossification through SOX9, we also performed a rescue experiment in which SOX9 silencing restored the low expression of RUNX2 and collagen type X produced by downregulated miR-1-3p expression. Finally, the elevated SOX9 levels and reduced RUNX2 and collagen type X levels in the ARC of rabbits with DDH were also verified using immunohistochemistry, RT-PCR, and western blots. Conclusion: The relatively low expression of miR-1-3p in the ARC may be the cause of abnormal endochondral ossification in the acetabular roof of animals with DDH.

Secreted frizzled-related protein 3 was genetically and functionally associated with developmental dysplasia of the hip

Microstructure Changes and Mirna-Mrna Network in a Developmental Dysplasia of the Hip Rat Model

Downregulation of miR-1-3p expression inhibits the hypertrophy and mineralization of chondrocytes in DDH

Developmental dysplasia of the hip: linkage mapping and whole exome sequencing identify a shared variant in CX3CR1 in all affected members of a large multigeneration family

Abstract 257: Mir-217 Mediates the Protective Effects of the Dopamine D2 Receptor on Renal Inflammation and Fibrosis.

Secreted Frizzled-related protein 3 (sFRP3)-mediated suppression of interleukin-6 receptor release by A disintegrin and metalloprotease 17 (ADAM17) is abrogated in the osteoarthritis-associated rare double variant of sFRP3

FGFR3 Induces Degradation of BMP Type I Receptor to Regulate Skeletal Development.

Heterozygous LRP1 deficiency causes developmental dysplasia of the hip by impairing triradiate chondrocytes differentiation due to inhibition of autophagy

The Otto Aufranc Award: Identification of a 4 Mb region on chromosome 17q21 linked to developmental dysplasia of the hip in one 18-member, multigeneration family

Author Response for "A Genome-Wide Association Study Identifies New Genes Associated with Developmental Dysplasia of the Hip"

Comprehensive analysis of pathological changes in hip joint capsule of patients with developmental dysplasia of the hip

Lack Of Association Of A Single Nucleotide Polymorphism In Smoc1 With Developmental Dysplasia Of The Hip: A Case-Control Study

Expression of A Novel Splice Variant of Frmd7 in Developing Human Fetal Brains That is Upregulated Upon the Differentiation of Nt2 Cells

ASSOCIATION OF A SINGLE NUCLEOTIDE POLYMORPHISM IN TBX4 WITH DEVELOPMENTAL DYSPLASIA OF THE HIP: A CASE-CONTROL STUDY

Association of a Single Nucleotide Polymorphism in HOXB9 with Developmental Dysplasia of the Hip: A Case‐control Study

Review of susceptibility genes in developmental dysplasia of the hip: A comprehensive examination of candidate genes and pathways

Genetic Study on Developmental Dysplasia of the Hip.

Expression and Localization of FRMD7 in Human Fetal Brain, and a Role for F-actin.

Polymorphism in signal transduction is a major route through which osteoarthritis susceptibility is acting

Developmental dysplasia of the hip caused by homozygous TRIM33 pathogenic variant affecting downstream BMP pathway

A Novel Missense Variant in TXNDC3 is Associated with Developmental Dysplasia of the Hip in Han Chinese Population.